Banner KH - Search Results

1

Dual PDE3/4 inhibitors as therapeutic agents for chronic obstructive pulmonary disease.

Banner KH, Press NJ. Banner KH, et al. Br J Pharmacol. 2009 Jul;157(6):892-906. doi: 10.1111/j.1476-5381.2009.00170.x. Epub 2009 Jun 5. Br J Pharmacol. 2009. PMID: 19508401 Free PMC article. Review.

2

PDE4 inhibitors - a review of the current field.

Press NJ, Banner KH. Press NJ, et al. Among authors: banner kh. Prog Med Chem. 2009;47:37-74. doi: 10.1016/S0079-6468(08)00202-6. Prog Med Chem. 2009. PMID: 19328289 Review. No abstract available.

3

Exposing rodents to a combination of tobacco smoke and lipopolysaccharide results in an exaggerated inflammatory response in the lung.

Hardaker EL, Freeman MS, Dale N, Bahra P, Raza F, Banner KH, Poll C. Hardaker EL, et al. Among authors: banner kh. Br J Pharmacol. 2010 Aug;160(8):1985-96. doi: 10.1111/j.1476-5381.2010.00857.x. Br J Pharmacol. 2010. PMID: 20649596 Free PMC article.

4

Acute versus chronic administration of phosphodiesterase inhibitors on allergen-induced pulmonary cell influx in sensitized guinea-pigs.

Banner KH, Page CP. Banner KH, et al. Br J Pharmacol. 1995 Jan;114(1):93-8. doi: 10.1111/j.1476-5381.1995.tb14910.x. Br J Pharmacol. 1995. PMID: 7536098 Free PMC article.

5

Possible Contribution of Prostaglandin E2 to the antiproliferative effect of phosphodiesterase 4 inhibitors in human mononuclear cells.

Banner KH, Hoult JR, Taylor MN, Landells LJ, Page CP. Banner KH, et al. Biochem Pharmacol. 1999 Nov 1;58(9):1487-95. doi: 10.1016/s0006-2952(99)00223-3. Biochem Pharmacol. 1999. PMID: 10513992

6

TRP channels: emerging targets for respiratory disease.

Banner KH, Igney F, Poll C. Banner KH, et al. Pharmacol Ther. 2011 Jun;130(3):371-84. doi: 10.1016/j.pharmthera.2011.03.005. Epub 2011 Mar 21. Pharmacol Ther. 2011. PMID: 21420429 Review.

7

Identification and quantification of phosphodiesterase 4 subtypes in CD4 and CD8 lymphocytes from healthy and asthmatic subjects.

Landells LJ, Szilagy CM, Jones NA, Banner KH, Allen JM, Doherty A, O'Connor BJ, Spina D, Page CP. Landells LJ, et al. Among authors: banner kh. Br J Pharmacol. 2001 Jul;133(5):722-9. doi: 10.1038/sj.bjp.0704120. Br J Pharmacol. 2001. PMID: 11429397 Free PMC article.

8

Differential effect of phosphodiesterase 4 inhibitors on the proliferation of human peripheral blood mononuclear cells from normals and subjects with atopic dermatitis.

Banner KH, Roberts NM, Page CP. Banner KH, et al. Br J Pharmacol. 1995 Dec;116(8):3169-74. doi: 10.1111/j.1476-5381.1995.tb15120.x. Br J Pharmacol. 1995. PMID: 8719792 Free PMC article.

9

PDE4 inhibition: a novel approach for the treatment of inflammatory bowel disease.

Banner KH, Trevethick MA. Banner KH, et al. Trends Pharmacol Sci. 2004 Aug;25(8):430-6. doi: 10.1016/j.tips.2004.06.008. Trends Pharmacol Sci. 2004. PMID: 15276712 Review.

10

Macroscopic, microscopic and biochemical characterisation of spontaneous colitis in a transgenic mouse, deficient in the multiple drug resistance 1a gene.

Banner KH, Cattaneo C, Le Net JL, Popovic A, Collins D, Gale JD. Banner KH, et al. Br J Pharmacol. 2004 Nov;143(5):590-8. doi: 10.1038/sj.bjp.0705982. Epub 2004 Oct 4. Br J Pharmacol. 2004. PMID: 15466445 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page